Connection

Sergio Raposeiras-Roubín to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Sergio Raposeiras-Roubín has written about Drug Administration Schedule.
Sergio Raposeiras-Roubín
Connection Strength
0.029
Drug Administration Schedule
  1. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. Eur J Prev Cardiol. 2020 05; 27(7):696-705.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.